The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
DNA nanorobots—tiny, self-assembling machines capable of detecting diseases in blood samples within 2–4 hours
InflaRx is streamlining operations and largely discontinuing non-essential activities outside izicopan’s development
Mepolizumab is the first and only monthly biologic in China tested for COPD patients with blood eosinophil counts (BEC) as low as 150 cells/µL
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Subscribe To Our Newsletter & Stay Updated
